
Loading, please wait...

Loading, please wait...

Circular RNAs (circRNAs) represent a unique class of noncoding RNAs that mammals produce post-transcriptionally. Unlike other RNA classes, these molecules exist as closed loops without 5' or 3' ends. Recent research reveals that the human body produces over 100,000 unique circRNAs containing various combinations of exons and introns. Specifically, circRNAs in CNS injury play a vital role in determining patient outcomes by controlling secondary damage mechanisms. Therefore, understanding their formation and degradation pathways is essential for developing new neuroprotective strategies.
Furthermore, these molecules significantly influence the inflammatory response following traumatic events. They also regulate oxidative stress and apoptosis, which directly affects neuronal survival. Consequently, circRNAs act as key players in neuronal plasticity and functional recovery. Clinicians now view these RNAs as more than just genomic leftovers. Moreover, they act as "sponging" agents for microRNAs to modulate gene expression effectively.
This molecular interaction helps manage the complex cascade of events after an acute central nervous system injury. For instance, some circRNAs promote neuroprotection while others might exacerbate damage. However, researchers must further investigate how to target these molecules effectively in clinical settings. Understanding these mechanisms offers a potential pathway for improving recovery in patients with traumatic brain injury (TBI) and spinal cord injury (SCI). By focusing on these circular loops, scientists hope to unlock new treatments for neurotrauma.
Unlike linear RNAs, circRNAs possess a covalently closed-loop structure. This unique shape makes them highly resistant to degradation by RNA-exonucleases, allowing them to remain stable within the cellular environment for longer periods than their linear counterparts.
They regulate critical biological processes such as inflammation, autophagy, and neuronal plasticity. By acting as microRNA sponges, they control the expression of genes that either protect or damage neural tissue following trauma.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Arruri V et al. Role of Circular RNAs in Traumatic Brain Injury and Spinal Cord Injury. J Neurotrauma. 2026 May 09. doi: 10.1177/08977151261449704. PMID: 42104786.
Zhang X, et al. Circular RNA in Acute Central Nervous System Injuries: A New Target for Therapeutic Intervention. Front Mol Neurosci. 2022;15:816182.
Mehta SL, et al. Physiological and pathological functions of circular RNAs in the nervous system. J Neurosci Res. 2020;98(10):1878-1888.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Circular RNAs (circRNAs) are unique molecules that play a significant role in managing inflammation and recovery after traumatic brain and spinal cord injur...
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today